Fusion Antibodies PLC
LSE:FAB

Watchlist Manager
Fusion Antibodies PLC Logo
Fusion Antibodies PLC
LSE:FAB
Watchlist
Price: 6.35 GBX -3.79%
Market Cap: 7.2m GBX

Wall Street
Price Targets

FAB Price Targets Summary
Fusion Antibodies PLC

There are no price targets for FAB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Fusion Antibodies PLC Competitors:
Price Targets
301333
R&G PharmaStudies Co Ltd
36% Upside
RVTY
Revvity Inc
39% Upside
688222
HitGen Inc
6% Downside
MEDP
Medpace Holdings Inc
3% Upside
300404
Boji Medical Technology Co Ltd
35% Upside
GENO
Genovis AB
53% Upside
BANB
Bachem Holding AG
34% Upside
LONN
Lonza Group AG
17% Upside

Revenue
Forecast

Revenue Estimate
Fusion Antibodies PLC

For the last 8 years the compound annual growth rate for Fusion Antibodies PLC's revenue is -3%. The projected CAGR for the next 1 year is 86%.

-3%
Past Growth
86%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Fusion Antibodies PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Fusion Antibodies PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-77%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is FAB's stock price target?
Not Available

FAB doesn't have any price targets made by Wall Street professionals.

What is Fusion Antibodies PLC's Revenue forecast?
Projected CAGR
86%

For the last 8 years the compound annual growth rate for Fusion Antibodies PLC's revenue is -3%. The projected CAGR for the next 1 year is 86%.

Back to Top